Special purpose acquisition company Glass House Group for $567 million. The deal implies a $1.024-billion equity valuation and an approximate enterprise valuation of $691 million. Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) purchased European operator EMMAC Life Sciences. The U.S.-based company agreed to pay $50 million in cash and 17.5 million in stock — worth roughly $260 million. In addition, Curaleaf teamed up with an institutional investor to secure $130 million in financing for further expansion of Curaleaf International. Meanwhile, Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced it will buy The Supreme Cannabis Company, Inc. (TSX:FIRE) (OTCQX:SPRWF) for about CA$435 million ($345.7 million).